Fenoterol increases erythropoietin concentrations during tocolysis

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • C. H. Gleiter - , University of Göttingen (Author)
  • K. H. Schreeb - , University of Göttingen (Author)
  • S. Goldbach - , University of Göttingen (Author)
  • S. Herzog - , University of Göttingen (Author)
  • T. Cunze - , University of Göttingen (Author)
  • W. Kuhn - , University of Göttingen (Author)

Abstract

Aims. The present study was carried out to assess the effect of the selective β2-adrenoceptor agonists on erythropoietin (EPO) production. Methods. Routine tocolysis with fenoterol (using the regular rate of 2 μg min-1) was used as a clinically easily accessible model. Results. EPO concentrations had doubled 24 h after the start of tocolysis (P < 0.001). This increase lasted over the entire observation period of 48 h. Potassium concentrations fell significantly during the first hours of fenoterol infusion. There was no increase of human placenta lactogen during the period of EPO increase. Conclusions. The data confirm our earlier results that fenoterol increases EPO concentrations following haemorrhage. In this model it was not necessary to stimulate EPO production prior to pharmacological treatment.

Details

Original languageEnglish
Pages (from-to)157-159
Number of pages3
JournalBritish journal of clinical pharmacology: BJCP
Volume45
Issue number2
Publication statusPublished - Feb 1998
Peer-reviewedYes
Externally publishedYes

External IDs

PubMed 9491829

Keywords

Keywords

  • Erythropoietin, Fenoterol, Human placenta lactogen, Metoprolol, Pregnancy, Tocolysis